Drug Profile
Research programme: Proto oncogene protein c-bcl-2 inhibitors - UCB
Alternative Names: UCB 1350883Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator UCB
- Class Small molecules
- Mechanism of Action Proto-oncogene protein c-bcl-2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer